Franklin Biotechnology Discovery R6 FRBRX
201.26 USD +6.44 (+3.31%)
At closeNov 6, 2026, 8:02 PM EST
Day range unavailable
173.67 52-week range 231.92
- YTD
- +12.15%
- 1 year
- +15.68%
- YTD return
- +12.15%
- 1-year return
- +15.68%
- Previous close
- 194.82
- 52-week range
- 173.67 – 231.92
2Y +33.56 (+20.81%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 152.71
- 200-day average
- 150.97
About Franklin Biotechnology Discovery R6
Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on FRBRX — it syncs with the Stock Master app.